Chris reviews new features of the MiniMed™ 780G system
I switched to MiniMed
My name is Chris, a MiniMed Champion who’s been living with type 1 diabetes for 35 years. On the day of my diagnosis, I was admitted to the hospital, and the next day I was learning how to inject using an orange (apparently the peel is a great stand-in for human skin) before injecting myself for the first time later that day!
I have gone from self-injection of native insulin (isolated from pigs) to recombinant insulin delivered by insulin pump, to now being on a hybrid closed loop system with MiniMed for nearly six years. And the closed loop system has truly changed my life, from the MiniMed™ 670G system to the MiniMed™ 770G, and now the MiniMedTM 780G system.
Don’t get me wrong, I haven’t always been on MiniMed products. I have previously used insulin pumps from two other companies and one CGM from another company. Access to the closed loop system is what really drove me to look deeper at and move to MiniMed.
My MiniMedTM 780G system experience
My experience has been truly amazing. It’s safe to say the MiniMedTM 780G system has made an improvement to my healthcare.
Top features
Here are the features I enjoy most:
1. Meal Detection™ technology.* Like everyone else, carb counting guesstimates don’t always work perfectly. The MiniMed™ 780G system deals with post-meal blood sugars more aggressively than just adjusting basal rates. It works great at keeping my blood sugar in range and back to goal.
2. Target glucose value. With the MiniMed™ 780G system, my healthcare provider and I get to choose my target blood glucose value (100, 110, or 120 mg/dL).** I have long wanted to have access to a lower target than previous systems would allow (120 mg/dL only).
3. New Guardian™ 4 transmitter and sensors (CGM). Now with Medtronic, I can stay in a closed loop system and no longer need to perform fingersticks to calibrate my sensor.† This has freed me from having to worry about when I was going to eat (and bolus) so that I wouldn’t have too much insulin on board when a calibration would be coming up. I am free to sleep when I want, wake up when I want, and eat when I want without worrying about when to calibrate!
4. Updated alarms and notifications. With the transition to the MiniMed™ 780G system and the Guardian™ 4 CGM, the frequency of alarms and notifications has dropped substantially from my experience with previous models. Honestly, I had silenced many of the non-urgent alarms on my pumps, but now with the MiniMed™ 780G system in SmartGuard™ mode, I almost never receive an alert on my pump unless it’s one of the brief instances where my blood sugar value has gone out of my upper or lower target range.
More freedom to exercise
I am a bit of an exercise enthusiast (running eight full marathons and completing all six of the World Marathon Majors). The MiniMed™ 780G system has allowed me more freedom to exercise without worrying about whether or not my blood sugar levels are behaving properly before my workout (using temp target well in advance) or after my workout (helping to ensure that post-exercise and meal hypoglycemia is dealt with in advance!).
I was doing fine before transitioning to the MiniMed™ 780G system, but I have been doing even better since I did the upgrade.
My recommendation
My experience with the MiniMed™ 780G system for nearly three months has truly been amazing. I can do more and not worry about my post-meal blood sugar, frequent calibrations, and waking up on time to make sure I calibrated my CGM.
It has given me more freedom to do what I want, when I want, and allow my diabetes management to be back of mind – I leave it to the system to do its thing! I tell everyone I know how great the system is and how it’s worth checking out to see if it can make your life with diabetes easier, and most importantly, better!
Important Safety Information: MiniMedTM 780G system with SmartGuardTM technology with Instinct sensor, Simplera SyncTM sensor, and GuardianTM 4 sensor
The MiniMedTM 780G system is intended for the continuous delivery of basal insulin at selectable rates and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose vales in the fluid under the skin.
The MiniMedTM 780G System includes SmartGuardTM technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera SyncTM and GuardianTM 4 sensors and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.
WARNING: Do not use the SmartGuardTM feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuardTM feature.
WARNING: Do not use MiniMedTM 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of MiniMedTM 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuardTM feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including accessories and additional important safety information concerning indications, contraindications, warnings and precautions associated with the system and its components, please consult https://www.minimed.com/important-safety-information and the appropriate user guide at https://www.minimed.com/support/download-library.
©2026 MiniMed. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2026 Abbott. TM*Third–party brands are trademarks of their respective owners.
DreaMed Diabetes is a trademark of DreaMed Diabetes, Ltd. The MiniMedTM 780G system algorithm includes technology developed by DreaMed Diabetes.